期刊文献+

三阴性乳腺癌的临床病理特征和预后影响因素分析 被引量:18

Clinicopathological features and prognostic factors of triple-negative breast cancer
在线阅读 下载PDF
导出
摘要 目的探讨三阴性乳腺癌(TNBC)的临床病理特征和预后影响因素。方法收集547例女性乳腺癌患者的病历及随访资料,患者分为TNBC组和非三阴性乳腺癌(non-TNBC)组,分析TNBC的临床病理特征和预后影响因素。结果 TNBC组和non-TNBC组的患者数分别为71(13.0%)和476(87.0%)。TNBC组与non-TNBC组患者年龄<35岁(14.1%vs1.1%)、有乳腺癌家族史(29.6%vs9.2%)、肿瘤直径>50 mm(22.5%vs8.0%)、肿瘤分期Ⅲ期(23.9%vs16.4%)、肿瘤分级Ⅲ级(40.8%vs28.8%)、有转移或复发(28.2%vs10.9%)等指标的差异均具有统计学意义(P<0.01或P<0.05),绝经状态、转移淋巴结数、病理类型、手术方式等指标差异均无统计学意义(P>0.05)。Kaplan-Meier生存分析显示,TNBC组患者5年无病生存率(DFS)和5年总生存率(OS)均显著低于non-TNBC组患者(65.8%vs85.3%,P<0.01;77.7%vs88.7%,P<0.05)。Cox比例风险回归模型分析显示,乳腺癌家族史、肿瘤分级和转移淋巴结数是影响TNBC组患者DFS的独立预后危险因素。结论与non-TNBC患者相比,TNBC患者发病年龄轻、有明显乳腺癌家族史、肿瘤体积大、肿瘤分期晚、肿瘤分级高、易复发转移、DFS和OS低、预后差。 Objective To investigate the clinicopathological features and prognostic factors of triple-negative breast cancer(TNBC). Methods A total of 547 females with breast cancer were selected,and were divided into TNBC group and non-TNBC group.The clinicopathological features and prognostic factors of TNBC were analysed. Results The numbers of patients in TNBC group and non-TNBC group were 71(13.0%) and 476(87.0%),respectively.There were significant differences in the parameters of age low than 35 years(14.1% vs 1.1%),family history of breast cancer(29.6% vs 9.2%),diameter of tumor longer than 50 mm(22.5% vs 8.0%),tumor stage Ⅲ(23.9% vs 16.4%),tumor grade Ⅲ(40.8% vs 28.8%)and recurrence or metastasis(28.2% vs 10.9%) between TNBC group and non-TNBC group(P<0.01 or P<0.05),while there was no significant difference in the parameters of menopausal status,number of lymph node metastasis,pathological types and surgical approach between these two groups(P>0.05).Kaplan-Meier survival analysis indicated that both 5-year disease-free survival(DFS) and 5-year overall survival(OS) in TNBC group were significantly lower than those in non-TNBC group(65.8% vs 85.3%,P<0.01;77.7% vs 88.7%,P<0.05).Cox proportional hazard regression model analysis revealed that family history of breast cancer,tumor stage and number of lymph node metastasis were independent prognostic risk factors for DFS of TNBC. Conclusion Compared with patients with non-TNBC,patients with TNBC are younger,more often have family history of breast cancer,have larger tumor size,more advanced tumor stage and higher tumor grade,are more prone to recurrence and metastasis,and have lower DFS,lower OS and poorer prognosis.
出处 《上海交通大学学报(医学版)》 CAS CSCD 北大核心 2011年第5期637-641,共5页 Journal of Shanghai Jiao tong University:Medical Science
关键词 乳腺肿瘤 三阴性 雌激素受体 孕激素受体 人表皮生长因子受体2 临床特征 预后 breast neoplasm triple-negative estrogen receptor progesterone receptor human epidermal growth factor receptor 2 clinical characteristics prognosis
  • 相关文献

参考文献22

  • 1Rebecca Dent,Wedad M. Hanna,Maureen Trudeau,Ellen Rawlinson,Ping Sun,Steven A. Narod.Pattern of metastatic spread in triple-negative breast cancer[J]. Breast Cancer Research and Treatment . 2009 (2)
  • 2David S. P. Tan,Caterina Marchió,Robin L. Jones,Kay Savage,Ian E. Smith,Mitch Dowsett,Jorge S. Reis-Filho.Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients[J]. Breast Cancer Research and Treatment . 2008 (1)
  • 3Joan E. Cunningham,William M. Butler.Racial disparities in female breast cancer in South Carolina: clinical evidence for a biological basis[J]. Breast Cancer Research and Treatment . 2004 (2)
  • 4Sorlie T,Tibshirani R,Parker J,et al.Repeated observation of breast tumor subtypes in independent gene expression data sets. Proceedings of the National Academy of Sciences of the United States of America . 2003
  • 5Carey LA,Perou CM,Livasy CA,et al.Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study. Journal of the American Medical Association, The . 2006
  • 6Sorlie T,Perou CM,Tibshirani R,et al.Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proceedings of the National Academy of Sciences of the United States of America . 2001
  • 7Dent R,Trudeau M,Pritchard KI,et al.Triple-negative breast cancer: clinical features and patterns of recurrence. Clinical Cancer Research . 2007
  • 8Perou CM,Sorlie T,Eisen MB,et al.Molecular portraits of human breast tumours. Nature . 2000
  • 9Minn AJ,Gupta GP,Siegel PM,et al.Genes that mediate breast cancer metastasis to lung. Nature . 2005
  • 10Jemal A,Siegel R,Ward E,et al.Cancer statistics, 2008. CA a Cancer Journal for Clinicians . 2008

同被引文献126

  • 1海涛,康骅,梁阔,张雁,张锋良.56例乳腺癌内腔镜腋窝淋巴结清扫的临床分析[J].首都医科大学学报,2008,29(3):377-380. 被引量:13
  • 2王蓓,傅健飞,吕晓皑.74例三阴性乳腺癌临床特征及预后分析[J].肿瘤学杂志,2009,15(11):1005-1008. 被引量:6
  • 3李宝江,朱志华,王军业,侯景辉,赵进明,张蓬原,姚广裕,王曦,龙浩,杨名添,戎铁.Ki67、P53、VEGF和C-erbB-2在乳腺癌组织中表达的相关性研究及其临床意义[J].癌症,2004,23(10):1176-1179. 被引量:126
  • 4<乳腺癌HER2检测指南>编写组,霍临明.乳腺癌HER2检测指南[J].中华病理学杂志,2006,35(10):631-633. 被引量:165
  • 5Rakha EA, Reis-Filho JS, Ellis IO. Basal-like breast cancer: aeriti:al review [ J ]. J C/in Oneol, 2008, 26 ( 15 ) : 2568 - 2581.
  • 6Dent R, Trudeau M, Pritchard KI, et al. Triple-negative breast cancer: clinical features and patterns of recurrence[J] Clin Cancer Res, 2007, 13(15 Pt 1): 4429-4434.
  • 7Shiu KK, Tan DS, Reis-Filho JS. Development of therapeutic approaches to ' triple negative' phenotype breast cancer[J]. Expert Opin Ther Targets, 2008, 12(9): 1123-1137.
  • 8Rakha EA, EI-Sayed ME, Green AIR, et al. Prognostic markers in triple-negative breast cancer[J]. Cancer, 2007, 109 ( 1 ) : 25 - 32.
  • 9Yin WJ, Lu Js, Di GH, et al. Clinicopathological features of the triple-negative tumors in Chinese breast cancer patients[ J]. Breast Cancer Res Treat, 2009, 115(2) : 325 -333.
  • 10Carey LA, Dees EC, Sawyer L, ct al. The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes [ J]. Clin Cancer Res, 2007, 13(8) : 2329 -2334.

引证文献18

二级引证文献131

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部